Published in World J Hepatol on November 08, 2015
Surgery is the preferred treatment for bile duct hamartomas. Mol Clin Oncol (2017) 0.75
Autophagy mediates the mitotic senescence transition. Genes Dev (2009) 6.80
Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma. Gut (2003) 3.91
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. Oncologist (2011) 3.05
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. Gastroenterology (2011) 2.63
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology (2013) 2.42
The hepatic von Meyenburg complex: prevalence and association with hepatic and renal cysts among 2843 autopsies [corrected]. Mod Pathol (1996) 2.03
Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? Hepatology (2012) 1.94
Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver. Gut (2000) 1.89
Bile duct adenoma. A study of 152 cases. Am J Surg Pathol (1988) 1.87
Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma. Hum Pathol (2012) 1.51
Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol (2007) 1.51
Von Meyenburg complexes of the liver: imaging findings. J Comput Assist Tomogr (1998) 1.49
Evidence for the neoplastic transformation of Von-Meyenburg complexes. Am J Surg Pathol (2000) 1.48
Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma. Clin Cancer Res (2006) 1.44
The so-called bile duct adenoma is a peribiliary gland hamartoma. Am J Surg Pathol (1996) 1.40
Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma. BMC Cancer (2011) 1.36
Cholangiocarcinoma arising in bile duct adenoma with focal area of bile duct hamartoma. Virchows Arch (1995) 1.32
Intrahepatic cholangiocarcinoma arising in multiple bile duct hamartomas: report of two cases and review of the literature. Eur J Gastroenterol Hepatol (2009) 1.31
Bile duct adenomas as liver nodules. Arch Surg (1978) 1.30
Biliary adenofibroma: a rare neoplasm of bile duct origin with an indolent behavior. Am J Surg Pathol (2003) 1.28
Cholangiocarcinoma arising in von Meyenburg complexes: report of four cases. Pathol Int (2008) 1.27
Clinicopathologic features of intraductal papillary neoplasm of the bile duct according to histologic subtype. Am J Gastroenterol (2011) 1.26
Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways. Mod Pathol (2013) 1.22
Biliary adenofibroma with malignant transformation and pulmonary metastases: CT findings. AJR Am J Roentgenol (2002) 1.22
Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts. World J Hepatol (2009) 1.21
Biliary adenofibroma. A heretofore unrecognized benign biliary tumor of the liver. Am J Surg Pathol (1993) 1.18
Intraductal papillary neoplasms of the bile duct. Int J Hepatol (2014) 1.14
Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion. Am J Surg Pathol (2011) 1.12
Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis. Liver Int (2007) 1.10
Cholangiocarcinoma occurring in a liver with multiple bile duct hamartomas (von Meyenburg complexes). Arch Pathol Lab Med (2000) 1.10
KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas. Cancer (2013) 1.09
Over-expression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis. J Pathol (2008) 1.09
A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas. Hum Pathol (2011) 1.09
Frequent loss of chromosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma. J Hepatol (2002) 1.08
Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm. Hum Pathol (2008) 1.07
BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma. Mod Pathol (2013) 1.06
Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver. Dig Dis Sci (2000) 1.05
Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma. J Pathol (2002) 1.05
Biliary adenofibroma of the liver: report of a case and review of the literature. Patholog Res Int (2010) 1.04
Pattern of chromosomal aberrations in primary liver cancers identified by comparative genomic hybridization. Hum Pathol (2009) 1.03
Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract. Hum Pathol (2003) 1.02
Autophagy mediates the process of cellular senescence characterizing bile duct damages in primary biliary cirrhosis. Lab Invest (2010) 1.01
Microsatellite instability and alternative genetic pathway in intrahepatic cholangiocarcinoma. J Hepatol (2001) 1.01
Molecular evidence for the neoplastic potential of hepatic Von-Meyenburg complexes. Appl Immunohistochem Mol Morphol (2010) 1.00
Monosomy 22 in a case of biliary adenofibroma. Cancer Genet Cytogenet (1997) 0.96
Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type. J Hepatobiliary Pancreat Sci (2014) 0.95
Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinoma. Histopathology (1999) 0.95
Intraductal papillary neoplasms of bile duct. A distinct entity like its counterpart in pancreas. Histol Histopathol (2008) 0.93
Cholangiocarcinoma arising from preexisting biliary hamartoma of liver--report of a case. Hepatogastroenterology (2003) 0.93
Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Genet Cytogenet (2001) 0.92
What are the precursor and early lesions of peripheral intrahepatic cholangiocarcinoma? Int J Hepatol (2014) 0.92
Proposal of a new disease concept "biliary diseases with pancreatic counterparts". Anatomical and pathological bases. Histol Histopathol (2013) 0.92
Adenoma-carcinoma sequence in intrahepatic cholangiocarcinoma. Int J Surg Case Rep (2012) 0.89
Biliary neoplasia with extensive intraductal spread associated with liver cirrhosis: a hitherto unreported variant of biliary intraepithelial neoplasia. Hum Pathol (2008) 0.89
K-ras mutation is strongly associated with perineural invasion and represents an independent prognostic factor of intrahepatic cholangiocarcinoma after hepatectomy. Ann Surg Oncol (2012) 0.88
Pathological diagnosis of flat epithelial lesions of the biliary tract with emphasis on biliary intraepithelial neoplasia. J Gastroenterol (2013) 0.88
Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct. Histopathology (2012) 0.87
Chromosomal imbalances in Korean intrahepatic cholangiocarcinoma by comparative genomic hybridization. Cancer Genet Cytogenet (2005) 0.85
Autoimmune pancreatitis and biliary intraepithelial neoplasia of the common bile duct: a case with diagnostically challenging but pathogenetically significant association. Pathol Int (2011) 0.85
Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type. Am J Surg Pathol (2011) 0.85
Choledochal cysts: a clinicopathologic study of 36 cases with emphasis on the morphologic and the immunohistochemical features of premalignant and malignant alterations. Hum Pathol (2014) 0.85
Histological and immunohistological findings in biliary intraepithelial neoplasia arising from a background of chronic biliary disease compared with liver cirrhosis of non-biliary aetiology. Histopathology (2011) 0.81
Malignant Transformation in Von-Meyenburg Complexes: Histologic and Immunohistochemical Clues With Illustrative Cases. Appl Immunohistochem Mol Morphol (2015) 0.78
Histological Characterization of Biliary Intraepithelial Neoplasia with respect to Pancreatic Intraepithelial Neoplasia. Int J Hepatol (2014) 0.78
Autophagy may occur at an early stage of cholangiocarcinogenesis via biliary intraepithelial neoplasia. Hum Pathol (2014) 0.77
Intraductal papillary cholangiocarcinoma associated with von Meyenberg complexes: a case report. Dig Dis Sci (2007) 0.77
BRAF V600E mutational status in bile duct adenomas and hamartomas. Histopathology (2015) 0.77
The development of cholangiocarcinoma from multiple bile-duct adenomas. Report of a case and review of the literature. Acta Pathol Microbiol Immunol Scand A (1984) 0.76
Biliary intraepithelial neoplasia (BilIN) is frequently found in surgical margins of biliary tract cancer resection specimens but has no clinical implications. Virchows Arch (2014) 0.76
Cholangiocarcinoma arising in Von Meyenburg complex associated with hepatocellular carcinoma in genetic haemochromatosis. Eur J Gastroenterol Hepatol (2000) 0.76